Colonization dynamics of ampicillin-resistant Escherichia coli in the infantile colonic microbiota

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 4, 2008, Pages 703-708

  Karami, Nahid ^a   Hannoun, Charles ^a   Adlerberth, Ingegerd ^a   Wold, Agnes E ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

lactamases; E. coli; Persistence; Phylogeny; Virulence factors

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE OXA; BETA LACTAMASE SHV; BETA LACTAMASE TEM; CEFTAZIDIME; CEFTIBUTEN; CEPHALOSPORIN; ERYTHROMYCIN; NITROFURANTOIN; PENICILLIN G; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; CHILD HEALTH; COLON FLORA; CONTROLLED STUDY; DRUG USE; ESCHERICHIA COLI; FECES CULTURE; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; INFANT; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MICROBIAL POPULATION DYNAMICS; PENICILLIN RESISTANCE; PHYLOGENY;

AMPICILLIN; AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COLON; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FECES; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; VIRULENCE FACTORS;

EID: 52949121465     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn263     Document Type: Article

References (38)

1. Cooke EM. Escherichia coli: Distribution in nature and epidemiology. In: Cooke EM, ed. Escherichia coli and Man. Edinburgh, UK: Churchill Livingstone, 1974.
2. Sahm DF, Thornsberry C, Mayfield DC et al. Multidrug-resistant urinary tract isolates of Escherichia coli: Prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 2001; 45: 1402-6.
3. Wilson HD, Eichenwald HF. Sepsis neonatorum. Pediatr Clin North Am 1974; 21: 571-82.
4. Zaman S, Jalil F, Karlberg J et al. Early child health in Lahore, Pakistan: VI. Morbidity. Acta Paediatr Suppl 1993; 82 Suppl 390: 63-78.
5. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4: 80-128.
6. Johnson JR, Delavari P, Kuskowski M et al. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 2001; 183: 78-88.
7. Bingen E, Picard B, Brahimi N et al. Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J Infect Dis 1998; 177: 642-50.
8. Sears HJ, Browniee E, Uchiyama JK. Persistence of individual strains of Escherichia coli in the intestinal tract of man. J Bacteriol 1949; 59: 299-301.
9. Sears HJ, Browniee I. Further observations on the persistence of individual strains of Escherichia coli in the intestinal tract of man. J Bacteriol 1951; 63: 47-57.
10. Sears HJ, James H, Saioum R et al. Persistence of individual strains of Escherichia coli in man and dog under varying conditions. J Bacteriol 1956; 71: 370-2.
11. Adlerberth I, Hanson LA, Svanborg C et al. Adhesins of Escherichia coli associated with extra-intestinal pathogenicity confer binding to colonic epithelial cells. Microb Pathog 1995; 18: 373-85.
12. Nowrouzian F, Wold AE, Adlerberth I. P fimbriae and aerobactin as intestinal colonization factors for Escherichia coli in Pakistani infants. Epidemiol Infect 2001; 126: 19-23.
13. Wold AE, Caugant DA, Lidin-Janson G et al. Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis 1992; 165: 46-52.
14. Nowrouzian F, Adlerberth I, Wold AE. P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli. Epidemiol Infect 2001; 126: 11-8.
15. Nowrouzian F, Hesselmar B, Saalman R et al. Escherichia coli in infants' intestinal microflora: Colonization rate, strain turnover, and virulence gene carriage. Pediatr Res 2003; 54: 8-14.
16. Nowrouzian FL, Wold AE, Adlerberth I. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J Infect Dis 2005; 191 1078-83.
17. Nowrouzian FL, Adlerberth I, Wold AE. Enhanced persistence in the colonic microbiota. of Escherichia coli strains belonging to phylogenetic group B2: Role of virulence factors and adherence to colonic cells. Microbes Infect 2006; 8: 834-40.
18. Karami N, Nowrouzian F, Adlerberth I et al. Tetracycline resistance in Escherichia coli and persistence in the infantile colonic microbiota. Antimicrob Agents Chemother 2006; 50: 156-61.
19. Catry B, Leavens H, Devriese LA et al. Antimicrobial resistance in livestock. J Vet Pharmacol Ther 2003; 26: 81-93.
20. Andersson DI. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 2006; 9: 461-5.
21. http://www.srga.org (8 May 2008, date last accessed).
22. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
23. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
24. Paterson DL. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006; 34: S20-8; discussion S64-73.
25. TEM genes and their promoters. Antimicrob Agents Chemother 2000; 44: 3232-4.
26. Martinez JL, Cercenado E, Rodriguez-Creixems M et al. Resistance to β-lactam/clavulanate. Lancet 1967; 11: 1473.
27. Adlerberth I, Lindberg E, Aberg N et al. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: An effect of hygienic lifestyle? Pediatr Res 2006; 59: 96-101.
28. Cavé H, Bingen E, Elion J et al. Differentiation of Escherichia coli strains using randomly amplified polymorphic DNA analysis. Res Microbiol 1994; 145: 141-50.
29. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
30. Belaaouaj A, Lapouméroulie C, Caniça MM et al. Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol Lett 1994; 120: 75-80.
31. Briñas L, Zarazaga M, Sa'enz Y et al. β-Lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother 2002; 46: 3156-63.
32. XA-1 genes in Enterobacteriaceae. FEMS Microbiol Lett 2003; 223: 147-51.
33. Olesen I, Hasman H, Aarestrup FM. Prevalence of β-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark. Microb Drug Resist 2004; 10: 334-40.
34. Domi'nguez E, Zarazaga M, Sa'enz Y et al. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain. Microb Drug Resist 2002; 8: 321-7.
35. Lidin-Janson G, Falsen E, Jodal U et al. Characteristics of antibiotic-resistant Escherichia coli in the rectum of healthy school-children. J Med Microbiol 1977; 10: 299-308.
36. Wu PJ, Shannon K, Phillips I. Mechanisms of hyperproduction of TEM-1 Β-lactamase by clinical isolates of Escherichia coli. J Antimicrob Chemother 1995; 36: 927-39.
37. Branger C, Zamfir O, Geoffroy S et al. Genetic background of Escherichia coli and extended-spectrum β-lactamase type. Emerg Infect Dis 2005; 11: 54-61.
38. Karami N, Mariner A, Enne VI et al. Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. J Antimicrob Chemother 2007; 60: 1142-5.